Recombinant clotting factors in the treatment of hemophilia.
Lee
C
C
Royal Free Hospital, Haemophilia Centre & Haemostasis Unit, London, England.
D005164:Factor IX / Q000191:economics / Q000627:therapeutic use*; D005169:Factor VIII / Q000191:economics / Q000276:immunology / Q000627:therapeutic use*; D015942:Factor VIIa / Q000627:therapeutic use; D017048:Health Care Costs; D006467:Hemophilia A / Q000188:drug therapy* / Q000191:economics / Q000276:immunology; D002836:Hemophilia B / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D007108:Immune Tolerance; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D006113:United Kingdom
D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII; D005164:Factor IX; D015942:Factor VIIa